Antihistamines such as diphenhydralin and promethrazine, which were commonly used in allergic reactions, could be used to relieve itching, redness, and other symptoms caused by allergy. However, they were generally not administered by intravenous injection. Instead, they were usually administered by intravenous injection or intravenous drip. Only when the allergic reaction was very serious would they be administered by intravenous injection. In allergic diseases such as hives, the main drugs used for intravenous injections were mainly Na thionate and calcium glyconate. They were non-specific anti-allergic drugs that had the effect of relieving itching, but they were not typical antihistamines. It should be noted that the medication used for allergy needs to be selected according to the patient's specific conditions, and the doctor's advice and guidance should be followed. Don't use your own medication. Read more exciting novels for free
The anti-arrythmic drugs used in the vein included lidocain, ammioduron, verapamil, cedilanid, propafenone, etc. Lidocain belongs to class I b drugs. It blocks the Na channel and is suitable for hemodynamically-stable entry-venous, entry-venous, or pulseless entry-venous. The loading dose is 1 - 1.5kg, and it can be repeated at intervals of 5 - 10 minutes, but the maximum dose is not more than 3kg. After the loading dose, the dosage should be maintained at 1 - 4kg/min by IV drip. The dosage should be reduced in cases of heart failure, liver or kidney malfunction. Amioduron was one of the three types of anti-arrythmic drugs. It could suppress the influx of Na ions in the atrium and cardiac muscle fibers and slow down the transmission speed. It could be used for both premature and premature heart beats. It was the "ace drug" and "panacea" for anti-arrythmic diseases. Verapamil was a derivative of papaverine and an antagonist of calcium ion influx. It was mainly used for the treatment of SVR. The indications for propafenone were superior-ventricularly twitchy heart, auricle flutter, and so on. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
At present, there was no information about new antihistamines used for skin allergy. Common antihistamines include first-generation antihistamines such as clondromethamine, diphenhydralin, cypromethamine, ketotifen, promethrazine, etc.; second-generation antihistamines such as loratadin, cetiriizine, ebastine, etc.; third-generation antihistamines such as desloratadin, fexofenadin, etc. These drugs can be used to treat skin allergy. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
The side effects of central antihistamines were as follows: 1. Central nervous system reactions: It can be manifested as calmness, drowsiness, headache, dizziness, etc. It should be used with caution in patients who are engaged in driving, working at heights, operating machines, etc. 2. Digestive tract reactions, including nausea, vomiting, dry mouth, lack of appetite, abdominal discomfort, etc. 3. Others: Individual patients may have itchy skin, rash, increased granules, decreased blood capillaries, liver and kidney function damage, etc. 4. For young patients, long-term use may lead to obese, irregular heartbeat, etc., but the overall occurrence rate is not high; elderly patients may cause symptoms such as urine retaining, dry mouth, elevated eye pressure, etc., especially for elderly patients with epilepsy, who need to pay special attention and regularly check eye pressure when using it. In addition, the elderly are prone to adverse reactions such as low blood pressure, mental confusion, dementia, and dizziness. 5. Pregnant women and nursing mothers should use central antihistamines with caution. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Another top story might be related to the use of intravenous therapy in treating specific diseases more effectively. Such as using intravenous medications to combat severe infections. Researchers are constantly looking for better drug combinations and delivery methods through intravenous means to enhance treatment outcomes. Also, there could be stories on improving the safety of intravenous therapy. This includes reducing the risk of infections associated with intravenous lines by implementing better hygiene protocols at hospitals and clinics.
There's no obvious link between antihistamines and The Walking Dead comic group. Antihistamines are for treating allergies, and The Walking Dead is a fictional comic about a zombie apocalypse. They're in completely different domains.
One common element is human error. Mistakes in dosage calculation, wrong drug administration, or improper insertion of the IV can lead to horror - like situations. For example, if a nurse miscalculates the dosage of a powerful drug and gives too much through the IV, it can have serious consequences for the patient.
It could show the steps clearly, like showing the tools being prepared and the actual insertion process in a simple and visual way.
In some horror stories related to intravenous procedures, there are instances of wrong medications being administered through the IV. For example, a patient was supposed to receive a mild painkiller but instead got a powerful antibiotic that they were allergic to. This led to anaphylactic shock, with the patient struggling to breathe and their body going into a violent reaction. It was a very dangerous and scary situation that thankfully was resolved in time.
The commonly used lysine-anticipating tablet in clinical practice can be used to reduce fever in children through intravenous infusion. It can reduce fever within one hour after the application of the drug, but it cannot be used more than four times within 24 hours. However, authoritative guidelines did not recommend the use of muscle injection and intravenous drip for children. As much as possible, oral drugs were safer than muscle injection and intravenous drip. In addition, when the child had fever and convulsions, he could use an IV injection of tranquilizer (0.3 to 0.5 milligrams per kilogram of body weight, the maximum amount of a single dose should not exceed 10 milligrams). If the convulsions were not relieved, he could use a Lumina needle (5 to 10 milligrams per kilogram of body weight, the maximum amount of a single dose should not exceed 100 milligrams). At the same time, he could use an anesthetic such as fluralin or paraments to reduce the fever, and use a venous channel with normal saline to facilitate emergency medication. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Different diseases had different requirements for the administration of different dissolving drugs: 1. * * Venous intravenous chemotherapy for acute ischamic stroke (commonly used drugs in China are rt-PA and urokinases)** - * * Attack time within 4.5 hours ** - **rt - PA**: - The standard dose was 0.9 milligrams per kilogram (the maximum dose was 90 milligrams), and 10% of the drugs were administered by IV drip within the first minute. The remaining 90% of the drugs were administered by IV drip for 1 hour. - For patients with acute ischamic stroke who had a high risk of bleeding, a low dose of 0.6 milligrams per kilogram (the maximum dose was 60 milligrams) could be selected based on factors such as the severity of the disease and the willingness of the family members. 15% of the total amount was injected into the vein within the first minute, and the remaining 85% was injected by infusion pump for 1 hour. - * * Urokinase **: Can be used when there is no condition to use rt-PA. 1 million-1.5 million IUs dissolved in 100 - 200 ml of normal saline, continuous infusion for 30 minutes. - * * The time of onset is 4.5 - 6 hours **: Urokinase can be used as the choice of the dissolving drug. - * * Patients with onset time between 4.5 and 9 hours (definite onset time) and with CT or MRI infusion mismatches (core of the liver is less than or equal to 70 ml, hypo-infusion/core of the liver is greater than 1.2, and penumbra of the liver is greater than 10 ml), as well as patients who are not suitable for mechanical embolectomy or have no plans for mechanical embolectomy **: Rt-PA intravenous chemotherapy should be used. - * * For patients with AIS who had a stroke after waking up, if the last normal time was more than 4.5 hours, the focal area on the MRI was <1/3 of the middle cerebral artery blood supply area, and there was no signal change on the flair, and the symptoms were found within 4.5 hours (Wake-UP study), or the CT or MRI infusion was not matched within 9 hours from the middle point of sleep, and patients who were not suitable for or did not plan to perform mechanical embolectomy (EXTEND study)**: rt-PA intravenous chemotherapy could be used. 2. * * Treatment of patients with acute ST-segment elevation myocardiac arrest with intravenous infusion of urokinases, streptokinases, and tissue-type plasminogen stimulators ** - * * Urokinase **: 1.5 million to 2 million units of urokinase are recommended to be administered by IV drip within 30 minutes. - * * Streptokinase **: 1.5 million units will be infused in 60 minutes. - * * Reconstructed tissue-type plasminogen activating agent (representative drugs are arteplase and tenecteplase)**: The application method is relatively complicated. It is recommended to administer 100 milligrams of the drug by IV within 90 minutes. First, inject 15 milligrams by IV, then continue to drip 50 milligrams within 30 minutes, and then drip 35 milligrams within the remaining 60 minutes. 3. * * General requirements before the application of a dissolving drug ** - Confirm that there are indications for intravenous chemotherapy and no contraindications, and sign the informed consent form for intravenous chemotherapy. - Venous chemotherapy should be carried out as soon as possible to avoid all possible delays and strive to shorten the time from admission to intravenous chemotherapy (DNT) within 60 minutes. - The patient should be admitted to the intensive care unit or stroke unit for monitoring. - Blood pressure and nerve function were examined regularly. During and within 2 hours after the end of the intravenous infusion therapy, blood pressure measurement and nerve function assessment were performed once every 15 minutes, then once every 30 minutes for 6 hours, and then once every hour until 24 hours after the treatment. - If severe headache, high blood pressure, nausea or vomiting occur, or if the signs and symptoms of the nervous system worsen, immediately stop using the dissolving drug and perform a brain CT examination. - If the blood pressure is greater than or equal to 180 mm of mercury or greater than or equal to 100 mm of mercury, the frequency of blood pressure monitoring should be increased, and antihypertensives should be given. - During the course of intravenous chemotherapy, physicians should be fully prepared to deal with emergency adverse reactions, including bleeding complications and vasogenic edema that may cause obstruction of the airways. - Nasal feeding tubes, ureters, and artery pressure tubes should be delayed if the patient's condition permits. - For patients who received intravenous infusion therapy, anti-Platelet drugs such as Aspirin should be started 24 hours after the infusion. If the patient has other special conditions (such as comorbid diseases), the use of anti-Platelet drugs within 24 hours after the infusion of Alteplase can be considered after the benefits are greater than the risks. - 24 hours after the onset of chemotherapy, the patient should undergo a CT/MRI scan of the brain before the administration of anticoagulators or antiplaque drugs. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>